Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Hits & Misses
    • Artificial Intelligence and Healthcare
    • Doctors & Hospitals
      • COVID-19 and Public Health
    • Policy & Legislation
      • Affordable Care Act
    • Health Economics & Costs
      • Cost of Healthcare
      • Drug Prices & Regulations
      • Health Reform
    • Health Insurance
      • Public Insurance
      • Medicare
    • Telemedicine
      • Medical Tourism
  • Goodman Institute
  • Contact
  • Search
The Goodman Institute Health Blog

Category: Drug Prices & Regulations

Thursday Links

Posted on November 14, 2024November 14, 2024 by John C. Goodman
  • Study: Residents of the European Union and Britain are twice as likely to die prematurely from exposure to gas stove pollutants than from a car crash.
  • American life expectancy is rising again.
  • Chris Jacobs: Health reforms for a Republican Congress.
  • With some exceptions, government health program cannot deny coverage for a drug just because the social costs are higher than the social benefits.
  • Medicare price controls on durable medical equipment have led to fewer new products, less innovation.
+

Wednesday Links

Posted on November 13, 2024November 13, 2024 by John C. Goodman
  • The case against sports gambling.
  • Pharma has a new ad targeting PBMs.
  • RFK Jr.: 600 people at the National Institutes of Health will be fired on day one of Trump’s second term.
  • RFK Jr.: “We’re not gonna take vaccines away from anybody.”
  • Josh Barro on what’s wrong with Blue cities.
  • Medicare Advantage plans sue CMS over star ratings. (Modern Healthcare)
+

Tuesday Links

Posted on November 12, 2024November 12, 2024 by John C. Goodman
  • There is bipartisan support for site neutral payment under Medicare. (Statenews)
  • The election was a big win for prediction markets.
  • The DEA wants to ban psychedelics drugs that could revolutionize mental health.
  • The pros and cons of statins.
  • Why are  biologics treated more favorably than small molecules when it comes to Medicare price negotiation?
+

Monday Links

Posted on November 11, 2024November 11, 2024 by John C. Goodman
  • What Trump and Robert F. Kennedy Jr. might do to undermine vaccines — and what they likely can’t. (Statnews)
  • Pharmacists are the ultimate gatekeepers to opioids and other narcotics. 
  • People with cash on hand have fewer emergency department visits related to behavioral health and substance use.
  • ”A typical 35-year-old in the bottom half of the income distribution faces the same chronic disease burden as a typical 50-year-old in the top half.”
+
  • Previous
  • 1
  • …
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • …
  • 237
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 42 other subscribers

Popular Topics

©2026 The Goodman Institute Health Blog | Website by Lexicom